Best and the worst-performing mutual fund categories in October 2021
In the month of October 2021, the banking sector witnessed a very good performance, which is the major reason for it becoming the best performer of the month, while the pharma sectoral category performed worst among other mutual fund categories. Both schemes are equity-oriented. The return of the banking sectoral category for one month is 5.92 per cent. Whereas, the one month return for the pharma sectoral category is -3.84 per cent.
Let’s look at the best as well as worst-performing funds or ETFs within the category of Banking Sector and Pharma Sector based on one month return:
Fund Name
|
1-Month Return (October 2021)
|
AUM (in crores) (As on 30th September 2021)
|
Kotak PSU Bank ETF
|
13.73%
|
₹137
|
Nippon India ETF PSU Bank BeES
|
13.73%
|
₹266
|
HDFC Banking ETF
|
4.51%
|
₹174
|
ICICI Prudential Bank ETF
|
4.51%
|
₹2,668
|
UTI Bank Exchange Traded Fund
|
4.51%
|
₹27
|
SBI ETF Nifty Bank Fund
|
4.50%
|
₹5,430
|
Fund Name
|
1-Month Return (October 2021)
|
AUM (in crores) (As on 30th September 2021)
|
SBI Healthcare Opportunities Fund
|
-4.89%
|
₹2,001
|
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund
|
-4.38%
|
₹3,074
|
UTI Healthcare Fund
|
-4.31%
|
₹880
|
IDBI Healthcare Fund
|
-4.15%
|
₹80
|
Mirae Asset Healthcare Fund
|
-4.11%
|
₹1,885
|
Axis Healthcare ETF
|
-4.09%
|
₹20
|
Let’s look at the top holdings of the above-mentioned top as well as worst performing funds:
Kotak PSU Bank ETF
|
Company Name
|
%Assets
|
State Bank of India
|
30.26
|
Bank of Baroda
|
17.20
|
Canara Bank
|
13.94
|
Punjab National Bank
|
13.47
|
Bank of India
|
5.96
|
SBI Healthcare Opportunities Fund
|
Company Name
|
%Assets
|
Sun Pharmaceutical Industries
|
11.45%
|
Cipla
|
8.85%
|
Dr. Reddy’s Lab
|
8.78%
|
Divi’s Laboratories
|
8.63%
|
Aurobindo Pharma
|
6.52%
|